Uncomplicated vaginal delivery in two consecutive pregnancies carried to term in a woman with osteogenesis imperfecta type I and bisphosphonate treatment before conception

被引：9

作者：

Chen, Chih-Ping ^{[1
,2
,3
,4
,5
,6
,7
]}

Lin, Shuan-Pei ^{[3
,8
,9
]}

Su, Yi-Ning ^{[10
]}

Huang, Jian-Pei ^{[1
]}

Chern, Schu-Rern ^{[3
]}

Su, Jun-Wei ^{[1
,11
]}

Wang, Wayseen ^{[3
,12
]}

机构：

[1] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan

[2] Mackay Med Coll, Dept Med, New Taipei City, Taiwan

[3] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan

[4] Asia Univ, Dept Biotechnol, Taichung, Taiwan

[5] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan

[6] Natl Yang Ming Univ, Inst Clin & Community Hlth Nursing, Taipei 112, Taiwan

[7] Natl Yang Ming Univ, Dept Obstet & Gynecol, Sch Med, Taipei 112, Taiwan

[8] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan

[9] Mackay Med Nursing & Management Coll, Taipei, Taiwan

[10] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan

[11] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan

[12] Tatung Univ, Dept Bioengn, Taipei 104, Taiwan

来源：

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY | 2012年 / 51卷 / 02期

关键词：

PAMIDRONATE TREATMENT; BONE-RESORPTION; ALENDRONATE; INHIBITION; COLLAGEN;

D O I：

10.1016/j.tjog.2012.04.029

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

[No abstract available]

引用

页码：305 / 307

页数：3

共 19 条

[1]

CARLSON JW, 1993, J REPROD MED, V38, P228

[2] Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: A report of four cases [J].

Chan, Brendan ;

Zacharin, Margaret .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (06) :2017-2020

[3] Prospective comparative case study of uterine collagen in a woman with osteogenesis imperfecta type 1 who had previously ruptured her uterus [J].

Christodoulou, S. ;

Freemont, A. J. ;

McVey, R. ;

Vause, S. .

JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 27 (07) :738-739

[4] Osteogenesis imperfecta: Mode of delivery and neonatal outcome [J].

Cubert, R ;

Cheng, EY ;

Mack, S ;

Pepin, MG ;

Byers, PH .

OBSTETRICS AND GYNECOLOGY, 2001, 97 (01) :66-69

[5] Collagen content and growth factor immunoexpression in uterine lower segment of type IA osteogenesis imperfecta: Relationship with recurrent uterine rupture in pregnancy [J].

Di Lieto, A ;

Pollio, F ;

De Falco, M ;

Iannotti, F ;

Mascolo, M ;

Somma, P ;

Staibano, S .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (02) :594-600

[6] Does Treatment With Bisphosphonates Endanger the Human Pregnancy? [J].

Djokanovic, Nada ;

Klieger-Grossmann, Chagit ;

Koren, Gideon .

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2008, 30 (12) :1146-1148

[7] Alendronate mechanism of action:: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro [J].

Fisher, JE ;

Rogers, MJ ;

Halasy, JM ;

Luckman, SP ;

Hughes, DE ;

Masarachia, PJ ;

Wesolowski, G ;

Russell, RGG ;

Rodan, GA ;

Reszka, AA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :133-138

[8] Bisphosphonates: Mechanisms of action [J].

Fleisch, H .

ENDOCRINE REVIEWS, 1998, 19 (01) :80-100

[9]

GRAEPEL P, 1992, ARZNEIMITTEL-FORSCH, V42-1, P654

[10] Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis [J].

Halasy-Nagy, JM ;

Rodan, GA ;

Reszka, AA .

BONE, 2001, 29 (06) :553-559

← 1 2 →